Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 346

Showing 1-25 of 346 citing articles:

Long-term cardiovascular outcomes of COVID-19
Yan Xie, Evan Xu, Benjamin Bowe, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 583-590
Open Access | Times Cited: 1604
Post-acute COVID-19 syndrome
David Montani, Laurent Savale, Nicolas Noël, et al.
European Respiratory Review (2022) Vol. 31, Iss. 163, pp. 210185-210185
Open Access | Times Cited: 213
Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19
Denise Battaglini, Miquéias Lopes‐Pacheco, Hugo C. Castro‐Faria‐Neto, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 146
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines
David K. Shay, Tom T. Shimabukuro, Frank DeStefano
JAMA Cardiology (2021) Vol. 6, Iss. 10, pp. 1115-1115
Closed Access | Times Cited: 110
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences
Berenice Martínez-Salazar, Melle Holwerda, Chiara Stüdle, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 85
The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
Shaymaa Khazaal, Julien Harb, Mohamad Rima, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2903-2903
Open Access | Times Cited: 73
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 53
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
Beneficial Properties of Bromelain
Paweł Hikisz, Joanna Bernasińska
Nutrients (2021) Vol. 13, Iss. 12, pp. 4313-4313
Open Access | Times Cited: 73
Long‐term side effects and lingering symptoms post COVID‐19 recovery
Mohammad Zarei, Deepanwita Bose, Masoud Nouri‐Vaskeh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 68
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association
Pei‐Ni Jone, Anitha S. John, Matthew E. Oster, et al.
Circulation (2022) Vol. 145, Iss. 19
Open Access | Times Cited: 57
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
Salvatore Pepe, Ann Gregory, A. Robert Denniss
Heart Lung and Circulation (2021) Vol. 30, Iss. 10, pp. 1425-1429
Open Access | Times Cited: 55
Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems
Nicholas L. DePace, Joe Colombo
Current Cardiology Reports (2022) Vol. 24, Iss. 11, pp. 1711-1726
Open Access | Times Cited: 39
Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment
Aydin Huseynov, İbrahim Akın, Daniel Duerschmied, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 389-389
Open Access | Times Cited: 36
Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities
Cameron Stotts, Vicente F. Corrales–Medina, Katey J. Rayner
Circulation Research (2023) Vol. 132, Iss. 6, pp. 751-774
Closed Access | Times Cited: 23
Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review
Christo Kole, Εleni Stefanou, Nikolaos Karvelas, et al.
Cardiovascular Drugs and Therapy (2023)
Open Access | Times Cited: 22
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21
Cardiovascular disease in SARS‐CoV‐2 infection
Kei Sato, Jane E. Sinclair, Habib Sadeghirad, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 40
Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease
Babak Andi, D. Kumaran, Dale F. Kreitler, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update
Yicheng Yang, Zhiyao Wei, Changming Xiong, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas
Alberto Palazzuoli, Marco Metra, Sean P. Collins, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3713-3736
Open Access | Times Cited: 28
The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review
Ruth Ashton, Bethan E. Philips, Mark A. Faghy
Progress in Cardiovascular Diseases (2023) Vol. 76, pp. 31-37
Open Access | Times Cited: 16
Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis
Priya Singh, Yogendra Bhaskar, Pulkit Verma, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 16
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top